An anthracycline with anticancer activity 1 mg


≥98% pure An anthracycline with anticancer activity 1 mg



LB-100 is an inhibitor of protein phosphatase 2A (PP2A) with anticancer activity.1 It reduces PP2A activity and is cytotoxic to BxPC-3 and PANC-1 cells (IC50s = 0.85 and 3.87 μM, respectively). LB-100 inhibits radiation-induced Rad51 focus formation and homologous recombination repair in PANC-1 and MiaPaCa-2 cells.2 In vivo, it increases tumor microvessel density and VEGF secretion and decreases tumor volume in a PANC-1 mouse xenograft model when administered at a dose of 2 mg/kg.1 LB-100 (1.5 mg/kg) enhances radiation-induced reductions in tumor volume in CNE1 and CNE2 radioresistant nasopharyngeal carcinoma mouse xenograft models.3WARNING This product is not for human or veterinary use.


There are no reviews yet.

Be the first to review “An anthracycline with anticancer activity 1 mg”

Your email address will not be published.

Got something to discuss?


Add to cart